Summary: Prescriptions Without the Markup

Gerald Pruitt is 71, a retired ironworker from Gary, Indiana, and he takes two medications: rosuvastatin for cholesterol and empagliflozin for his kidneys. Together they cost $1,100 a month at his local Walgreens. His pharmacist is a good pharmacist. When Gerald asked if she could do anything, she told him no, and she was telling the truth about the system she operates inside. Her dispensing software prices drugs according to a contract between her pharmacy and its pharmacy benefit manager, and that contract does not include a mechanism for her to find Gerald a lower price.

On a Saturday afternoon, Gerald’s daughter Keisha ran his two prescriptions through a buying agent. Rosuvastatin: $8 a month through Mark Cuban’s Cost Plus Drug Company. Empagliflozin: $0 through the manufacturer’s patient assistance program. Gerald now pays $8 a month for prescriptions that were costing him $1,100. The $1,092 difference was not a discount. It was the distance between what the system charged him and what his medications actually cost when someone was looking out for him.

The article walks through how American pharmacy pricing actually works, and the picture is not flattering. Three pharmacy benefit managers control roughly 80% of the U.S. prescription drug market. They negotiate prices with manufacturers, set reimbursement rates for pharmacies, and collect rebates from manufacturers that are not passed through to patients. The result is a system where the same drug at the same dose in the same city can cost $14 at one pharmacy and $380 at another. The difference is contracts. The opacity is the product.

GoodRx is addressed honestly, the way this series addresses everything. It provides real savings and has been doing so for years. It also sells prescription data to pharmaceutical manufacturers and pharmacy benefit managers. In 2023, GoodRx settled with the FTC for $1.5 million over unauthorized sharing of health data with advertising platforms. The savings are real. The privacy cost is real. A buying agent can use GoodRx’s pricing data as a comparison point without requiring the user to create an account or become the product.

Cost Plus Drug Company’s model is explained in full: manufacturer’s cost plus a flat 15% markup plus a $5 dispensing fee plus $5 shipping. The price for every drug is published on its website. Gerald’s rosuvastatin: roughly $4.50 a month. The limitation is the formulary: Cost Plus carries primarily generics. For Gerald’s empagliflozin, still under patent with no generic available, the agent looked elsewhere.

The elsewhere was Boehringer Cares, the manufacturer’s patient assistance program. Gerald, with his Social Security and pension totaling $2,400 a month, qualifies. He did not know the program existed. His pharmacist did not mention it because pharmacy staff are not trained to navigate manufacturer assistance programs and their software does not surface them. His doctor did not mention it because physicians are not reimbursed for the administrative time the application requires, and the time is substantial. The article is specific about why: the programs are complex by design, because the manufacturer benefits from low enrollment. The agent found the program, confirmed eligibility, pre-filled the application, and routed the physician signature through a portal Gerald’s doctor already uses. Eleven days from identification to enrollment.

Canadian pharmacies are covered for completeness, as an option for medications where no domestic alternative produces an affordable price and no patient assistance program exists. The FDA has historically exercised enforcement discretion for personal imports of 90-day supplies from CIPA-certified pharmacies. Orders take two to four weeks. Savings on branded medications can reach 50% to 80% of U.S. retail price. Gerald did not need this option, but many readers will.

The article closes with what it cannot do. Gerald’s Walgreens pharmacist caught a drug interaction two years ago that a mail-order pharmacy would not have caught, because he knew the patient and recognized the conflict with a new prescription from an urgent care clinic. No algorithm would have flagged it. Gerald still fills his blood pressure medication at Walgreens because the $12 monthly premium over Cost Plus is worth what that trust provides. The agent told him where Walgreens was the right choice and where it was not, and let him decide.

Read the full article on BlueMirror.life.